Vialwirebiotech, curated
July 22, 2026, 5:27 PM
June 4, 2026
- 4:53 PM · STAT News
- 3:59 PM · STAT News
- 12:00 PM · BioWorld12:00 PMSCOTUS breathes new life into skinny labels — BioWorld
- 12:00 PM · BioWorld12:00 PMAutobahn on the fast track with bipolar thyroid agonist — BioWorld
- 12:00 PM · BioWorld12:00 PMZynlonta Lotis position in DLBCL strains ADC shares — BioWorld
- 12:00 PM · BioWorld12:00 PMOna raises $86.6M series B for ADCs to treat advanced cancers — BioWorld
- 9:27 AM · BioPharma Dive9:27 AMAn ADC specialist sinks on safety concerns for blood cancer drug — BioPharma Dive
- 9:17 AM · STAT News
- 9:00 AM · BioWorld9:00 AMCEPI backs Pop Biotechnologies’ nanoparticle vaccine platform — BioWorld
- 9:00 AM · BioWorld9:00 AMSotio Biotech’s SOT-106 designated orphan drug for osteosarcoma — BioWorld
- 9:00 AM · BioWorld9:00 AMIdefine announces Kleefstra syndrome gene therapy collaboration — BioWorld
- 6:16 AM · Drug Discovery World6:16 AMIngenix raises €13m to scale AI drug development model — Drug Discovery World
- 5:28 AM · Pharmaceutical Technology5:28 AMCellares and TScan to assess automated manufacturing of TSC-101 therapy — Pharmaceutical Technology
- 3:00 AM · BioPharma Dive3:00 AMA Spanish biotech banks $87M to make differentiated ADCs — BioPharma Dive
- 1:20 AM · Science (News)1:20 AMHouse spending panel proposes slight raise for NIH in 2027 — Science (News)
June 3, 2026
- 11:14 PM · STAT News
- 4:45 PM · STAT News
- 12:02 PM · Drug Discovery World12:02 PMHerantis to advance Alzheimer’s treatment after FDA meeting — Drug Discovery World
- 12:00 PM · BioWorld12:00 PMCytomx, Regeneron expand bispecifics deal to potential $4B — BioWorld
- 12:00 PM · BioWorld12:00 PMMammogen raises $30M for blood-based breast cancer detection assay — BioWorld
- 11:57 AM · BioPharma Dive11:57 AMLegend surges on early data for ‘in vivo’ lymphoma cell therapy — BioPharma Dive
- 10:32 AM · Drug Discovery World10:32 AMFirst AI drug enters clinical development — Drug Discovery World
- 9:37 AM · Pharmaceutical Technology9:37 AMUS lawmakers reveal policy to curb collaboration with Chinese biotech — Pharmaceutical Technology
- 9:00 AM · BioWorld9:00 AMFAPα inhibitors disclosed in Chomix Biotech patent — BioWorld
- 9:00 AM · BioWorld9:00 AMSynnovation Therapeutics reports new PARG inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMTavo Biotherapeutics closes series A to advance ocular pipeline — BioWorld
- 9:00 AM · BioWorld9:00 AMIMU’s $53M series A to advance high-definition immune profiling tech — BioWorld
- 9:00 AM · BioWorld9:00 AMChangchun Genescience identifies new USP30 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMCSPC’s SYS-6063 gains Chinese trial clearance for SLE — BioWorld
- 9:00 AM · BioWorld9:00 AMBMS patents new CAMK2 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMMJFF awards grant to Montara Therapeutics’ mTOR program — BioWorld
- 9:00 AM · BioWorld9:00 AMSichuan Kelun-Biotech prepares GSPT1-degrading PROTACs — BioWorld
- 8:00 AM · Bloomberg — Technology8:00 AM23andMe Is Back as Nonprofit Aiming to Reach 100 Million Users — Bloomberg — Technology
- 7:00 AM · BioPharma Dive7:00 AMLilly, Ascidian link up in RNA exon editing pact — BioPharma Dive
- 6:04 AM · Pharmaceutical Technology6:04 AMContraline secures $92.5m to push male contraceptive into late-stage trials — Pharmaceutical Technology
- 5:53 AM · Drug Discovery World5:53 AMDrug could reduce tumours by 55%, results show — Drug Discovery World
- 5:36 AM · Pharmaceutical Technology5:36 AMAbbVie receives EC approval for Aquipta to treat migraine — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMApogee secures $1.3b to advance dermatitis treatment — Drug Discovery World
- 4:46 AM · Pharmaceutical Technology4:46 AMRoche’s giredestrant secures FDA priority review for breast cancer — Pharmaceutical Technology
June 2, 2026
- 7:44 PM · Pharmaceutical Technology7:44 PMASCO26: Bispecific antibody and RET fusion-targeting assets garner attention in NSCLC — Pharmaceutical Technology